Coronavirus
Potential game-changer in the Covid battle, FDA authorization sought for molnupiravir
Molnupiravir pill developed by Merck (MSD) and Ridgeback Biotherapeutics has been hailed as a potential game-changer when it comes to treating Covid-19...